CASE REPORT
Accepted on 15 Oct 2025
Case report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma
doi 10.3389/fimmu.2025.1697566
- 191 views
567
Total downloads
6,240
Total views and downloads
Submit your idea
You will be redirected to our submission process.
CASE REPORT
Accepted on 15 Oct 2025
ORIGINAL RESEARCH
Accepted on 08 Oct 2025
SYSTEMATIC REVIEW
Published on 29 Sep 2025
CASE REPORT
Published on 18 Sep 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.